Latest Headlines

  1. Revvity Introduces New IVD Reference Standards For Monitoring Oncology Diagnostic Testing Workflows 6/2/2025

    Revvity, Inc. today announced the launch of three Mimix reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from human samples for IVD use.

  2. QIAGEN Expands Portfolio For Minimal Residual Disease (MRD) Testing In Oncology With New Strategic Partnerships 6/2/2025

    QIAGEN today announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials to support pharma co-development projects for companion diagnostics.

     

  3. Labcorp Expands Oncology Portfolio To Improve Patient Care And Advance Cancer Research 5/30/2025

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio.

  4. Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility And Reliability To Labs 5/29/2025

    Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen Attune Xenith Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed and accurate insights from critical cellular samples.

  5. Scientist.com Adds Trial Insights To Clinical Labs Navigator Solution, Giving Researchers Instant Access To Global Clinical-Trial Intelligence 5/28/2025

    Scientist.com, the leading R&D procurement platform for the life sciences, today integrated Trial Insights—its real‑time clinical‑trial analytics tool—into Clinical Labs Navigator.

  6. Instant And Accurate Single Tube Code Reading 5/28/2025

    Micronic, renowned for its cutting-edge solutions in sample storage and laboratory automation, introduces the Tube Reader DT520.

  7. Cizzle Bio Expands Global Reach With Cayman Islands Launch Of Biomarker Blood Tests For Lung And Gastric Cancers 5/28/2025

    Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric cancers, has announced an agreement with Doctors Hospital in the Cayman Islands to provide its proprietary CIZ1B lung cancer test and DEX-G2 gastric cancer test for use in the hospital's clinical laboratory, offering patients earlier and more accurate detection of two of the world's deadliest cancers.

  8. Illumina Expands Clinical Oncology Portfolio Unlocking New Standard Of Care And Access To Precision Therapies 5/28/2025

    Illumina Inc. (NASDAQ: ILMN) today announced an expanded clinical oncology portfolio, unlocking the next new solutions to advance precision oncology and improve the standard of care.

  9. Guardant Health Introduces Nearly A Dozen Groundbreaking Smart Liquid Biopsy Applications For Guardant360 Liquid Test 5/27/2025

    Guardant Health, Inc a leading precision oncology company, today announced major new features for the Guardant 360 Liquid test that greatly expand its biomarker identification and cancer subtyping capabilities to help oncologists identify optimal treatment plans.

  10. Lumea Enhances Digital Pathology Platform With AI-Powered Urine Cytology Solution Through Aixmed Partnership 5/27/2025

    Lumea, a leading provider of primary clinical digital pathology solutions, today announced a new partnership with AIxMed, an innovator in AI diagnostics for urine cytology.